134 related articles for article (PubMed ID: 25730510)
1. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.
Baptista MJ; Garcia O; Morgades M; Gonzalez-Barca E; Miralles P; Lopez-Guillermo A; Abella E; Moreno M; Sancho JM; Feliu E; Ribera JM; Navarro JT
AIDS; 2015 Apr; 29(7):811-8. PubMed ID: 25730510
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes in AIDS-related diffuse large B-cell lymphoma in the setting roll out of combination antiretroviral therapy in South Africa.
de Witt P; Maartens DJ; Uldrick TS; Sissolak G
J Acquir Immune Defic Syndr; 2013 Sep; 64(1):66-73. PubMed ID: 23797692
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.
Vaidya R; Witzig TE
Ann Oncol; 2014 Nov; 25(11):2124-2133. PubMed ID: 24625454
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of people living with human immunodeficiency virus (HIV) with diffuse large B-cell lymphoma (DLBCL) in Shanghai, China.
Sun JJ; Liu L; Wang JR; Shen YZ; Qi TK; Wang ZY; Tang Y; Song W; Chen J; Zhang RF
Chin Med J (Engl); 2020 Dec; 133(23):2796-2802. PubMed ID: 33273327
[TBL] [Abstract][Full Text] [Related]
5. Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort.
Painschab MS; Kasonkanji E; Zuze T; Kaimila B; Tomoka T; Nyasosela R; Nyirenda R; Dhungel BM; Mulenga M; Chikasema M; Tewete B; Mtangwanika A; Chiyoyola S; Mhango W; Chimzimu F; Kampani C; Krysiak R; Shea TC; Montgomery ND; Fedoriw Y; Gopal S
Br J Haematol; 2019 Feb; 184(3):364-372. PubMed ID: 30450671
[TBL] [Abstract][Full Text] [Related]
6. Is cytotoxic chemotherapy for lymphoma currently feasible for patients in Malawi? A debate.
Crutchlow E; Miombe Y; Latham T
Malawi Med J; 2008 Dec; 20(4):120-3. PubMed ID: 19537393
[TBL] [Abstract][Full Text] [Related]
7. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy.
Castelli R; Schiavon R; Preti C; Ferraris L
Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049
[TBL] [Abstract][Full Text] [Related]
8. Differential survival of Brazilian patients with diffuse large B-cell lymphoma with and without HIV infection.
Ferreira MP; Thuler LCS; Bergmann A; Soares EA; Soares MA
AIDS; 2023 Dec; 37(15):2331-2338. PubMed ID: 37650761
[TBL] [Abstract][Full Text] [Related]
9. Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan.
Ma WL; Liu WD; Sun HY; Sheng WH; Hsieh SM; Wu SJ; Hung CC
J Microbiol Immunol Infect; 2024 Apr; ():. PubMed ID: 38632022
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of lymphomas and other cancers in HIV-infected patients.
Carbone A; Vaccher E; Gloghini A; Pantanowitz L; Abayomi A; de Paoli P; Franceschi S
Nat Rev Clin Oncol; 2014 Apr; 11(4):223-38. PubMed ID: 24614140
[TBL] [Abstract][Full Text] [Related]
11. HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.
Jacobson CA; Abramson JS
Adv Hematol; 2012; 2012():507257. PubMed ID: 22272202
[TBL] [Abstract][Full Text] [Related]
12. Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study.
Focà E; Cavaglià G; Rusconi S; Cascavilla A; Cenderello G; Re A; Casari S; van den Bogaart L; Zinzani PL; Caracciolo D; Di Perri G; Bonito A; Lucchini A; Cassola G; Viale P; Calcagno A
HIV Med; 2018 Jun; ():. PubMed ID: 29862615
[TBL] [Abstract][Full Text] [Related]
13. Still Far to Go With Characterisation of Molecular and Genetic Features of Diffuse Large B-Cell Lymphoma in People Living With HIV: A Scoping Review.
Manyau MCP; Zambuko B; Chatambudza M; Zhou DT; Manasa J
Oncol Rev; 2024; 18():1375291. PubMed ID: 38707485
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous Regression of Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma in an HIV-Positive Patient: A Case Report and Literature Review.
Khaw ELY; Gan WF; Zaidan NZ
Cureus; 2024 Mar; 16(3):e55790. PubMed ID: 38586647
[TBL] [Abstract][Full Text] [Related]
15. Two Different Extranodal Lymphomas in an HIV
Bertuzzi C; Sabattini E; Bacci F; Agostinelli C; Ferri GG
Case Rep Hematol; 2019; 2019():8959145. PubMed ID: 31662919
[TBL] [Abstract][Full Text] [Related]
16. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
Sise ME; Hirsch JS; Canetta PA; Herlitz L; Mohan S
AIDS; 2015 May; 29(8):941-6. PubMed ID: 25784440
[TBL] [Abstract][Full Text] [Related]
17. Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.
Abraham AG; Darilay A; McKay H; Margolick JB; Estrella MM; Palella FJ; Bolan R; Rinaldo CR; Jacobson LP
J Infect Dis; 2015 Oct; 212(7):1100-10. PubMed ID: 25762788
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
Bruyand M; Ryom L; Shepherd L; Fatkenheuer G; Grulich A; Reiss P; de Wit S; D Arminio Monforte A; Furrer H; Pradier C; Lundgren J; Sabin C;
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):568-77. PubMed ID: 25763785
[TBL] [Abstract][Full Text] [Related]
19. Role of intestinal myofibroblasts in HIV-associated intestinal collagen deposition and immune reconstitution following combination antiretroviral therapy.
Asmuth DM; Pinchuk IV; Wu J; Vargas G; Chen X; Mann S; Albanese A; Ma ZM; Saroufeem R; Melcher GP; Troia-Cancio P; Torok NJ; Miller CJ; Powell DW
AIDS; 2015 May; 29(8):877-88. PubMed ID: 25784439
[TBL] [Abstract][Full Text] [Related]
20. The role of dolutegravir in the management of HIV infection.
Miller MM; Liedtke MD; Lockhart SM; Rathbun RC
Infect Drug Resist; 2015; 8():19-29. PubMed ID: 25733917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
